U

UroGen Pharma, Inc

Develops RTGel-based drug delivery for uro-oncology

Medical Science Liaison

Biology & BiotechConfirmed live in the last 24 hours
Full-timeTexas, USANo salary listedRemote

About the Job

Requirements

  • A doctoral degree in a clinical specialty (M.D., Pharm.D., or PhD.) is required.
  • At least five years of experience following the last stage of training, including at least three years of experience in medical affairs or as an MSL in the pharmaceutical industry.
  • Experience in urology, oncology, or a related field.
  • Excellent oral and written communication skills, including presentation skills.
  • Demonstrated interpersonal skills and the ability to understand and respond to multiple external and internal customer demands and handle conflict constructively.
  • Clinical or scientific technical skills, including experience working with clinical trials.
  • Understanding of and adherence to standard operating procedures, rules, and regulations for internal and external company and customer interactions and activities.
  • Ability to manage a significant volume of field-based projects, prioritize, provide oversight, and exercise sound judgment.
  • Ability to work within the medical group and across multidisciplinary teams to accomplish responsibilities and goals.
  • Ability to leverage and navigate internal departments to accomplish multifaceted projects and duties.
  • Ability to collaborate and demonstrate leadership and teamwork with peers, internal stakeholders, and external customers to build alignment and partnership around a shared vision or strategy.
  • Ability to work independently, be accountable, and deliver results with urgency.

Responsibilities

  • Establish peer-to-peer relationships and engage in scientific exchange on research and clinical trends in urology, urologic oncology, and UroGen therapeutic areas across the product lifecycle.
  • Contribute to and represent the therapeutic strategy established by Medical Affairs and Clinical Development, aligned with the brand, while working with other departments and colleagues in the field and corporate offices.
  • Provide field-based clinical support to healthcare professionals by responding to unsolicited medical information requests, including payer requests; identify and facilitate clinical or scientific opportunities; and deliver educational presentations.
  • Support clinical development programs by translating external insights into company programs, contributing real-world input to study design and site selection, and supporting company-sponsored trials.
  • Help develop a clinical trials strategy for investigator-initiated trials.
  • Participate in regional symposia, medical advisory boards, and national and regional medical meetings.
  • Attend scientific conferences to gather and convey relevant scientific information to thought leaders and the company, maintain current scientific expertise, and provide medical information in compliant settings at exhibit booths as needed.
  • Assist in developing and leading larger-scale projects and relevant initiatives, and undertake team leadership and mentoring activities as directed or proactively identified.
  • Strengthen relationships between UroGen and the disease-area community through objective clinical education, support for research, and feedback on therapeutic products, clinical trends, and research; conduct peer-to-peer scientific exchange and communicate insights back to UroGen.

About the Company

UroGen Pharma, Inc

Develops RTGel-based drug delivery for uro-oncology

UroGen Pharma develops RTGel-based drug-delivery therapies for urothelial and specialty cancers, commercializing products like Jelmyto and ZUSDURI and advancing a pipeline that includes UGN-102, UGN-103, UGN-104, and UGN-301. Its RTGel platform is liquid at cool temperatures and gels at body temperature, allowing chemotherapy to stay at the treatment site longer for local, sustained exposure. The company differentiates itself by delivering established chemotherapy directly to the disease site to reduce systemic exposure and by building a multi-product portfolio focused on urothelial cancers. Its goal is to improve local treatment outcomes and grow a diversified, globally commercial portfolio through ongoing clinical development and partnerships.

Company size
201-500
Company stage
IPO
Headquarters
Princeton, NJ
Founded
2004

Recently Posted Jobs

Explore more opportunities at UroGen Pharma, Inc

See more jobs